+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

A COVID-19 vaccine will trigger a stock-market rotation into these 7 sectors, Goldman Sachs financial adviser says

Oct 4, 2020, 18:30 IST
Business Insider
A researcher works on a vaccine against the new coronavirus COVID-19 at the Copenhagen's University research lab in Copenhagen, Denmark, on March 23, 2020.THIBAULT SAVARY/AFP via Getty Images
  • Goldman Sachs' Erin Riley said the announcement of a COVID-19 vaccine will trigger a stock-market rotation into sectors that have been "deeply depressed" by the pandemic.
  • The sectors are: transportation, sports, hotels, restaurants, hospitals, food, and beverages.
  • This rotation could occur as early as the beginning of next year 2021, Riley said, citing super forecasters who expect enough doses of a vaccine to inoculate 25 million people to be ready by that time.
Advertisement

How and when to position for a post-vaccine world is the question at the top of many investors' minds right now. Erin Riley, a Goldman Sachs financial adviser, said the announcement of a COVID-19 vaccine will spark a rotation into seven specific sectors.

"Certain value sectors like food and beverages exhibit very high positive correlation with rising vaccine probabilities," Riley said on Friday's episode of the Exchanges at Goldman Sachs podcast.

She also said these sectors that were "deeply depressed" by the pandemic could be well positioned for a catch-up: transportation, sports, hotels, restaurants, and hospitals.

Riley said data is showing signs that this rotation could occur as early as 2021.

"The majority of super forecasters expect there to be enough doses of an FDA-approved COVID-19 vaccine to inoculate 25 million people some time at the beginning of next year," she added.

Advertisement

Read more: MORGAN STANLEY: Buy these 16 stocks to cheaply invest in next-generation technologies and reap the future profits they generate

Along with a vaccine catalyst, Riley's clients have looked at the "massively bifurcated" stock market, where large technology names have seen massive gains while other sectors haven't recovered their pandemic losses, as a signal that a rotation is due at some point in the future.

"The are essentially two economies trading, which suggests that the market remains very skeptical of any semblance of a return to normal. A lot of clients that I speak to are still constructive on growth technology stocks, which particularly owes to the low-rate environment and the acceleration in trends ignited by stay-at-home orders," Riley said.

She added: "But low-valuation stocks now trade at their largest discount to high valuation since the tech bubble. And tactically, many clients think at some point this gap simply needs to converge."

Read more: A Wall Street expert says a trend that with a 30-year track record of wrecking expensive stocks is flashing for big tech — and warns investors to brace for a turnaround within months

Advertisement
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article